Definition of the least toxic sequence (LTS) and optimal therapeutic dose of Yondelis (TM) (ET-743; trabectedin) in combination with doxorubicin (Doxo) in patients with untreated metastatic soft tissue sarcomas (STS) and advanced pre-treated anthracycline - Naive breast cancer patients (ABC)
Articolo
Data di Pubblicazione:
2003
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Gianni, L; Grasselli, G; De Braud, F; Curigliano, G; Noberasco, C; Marsoni, S; Bartosek, A; Perez, C; Jimeno, J; Zucchetti, M; D'Incalci, M; Vigano, L; Bianchini, G; Sessa, C
Link alla scheda completa:
Pubblicato in: